Soleno Therapeutics’ ‘life-changing’ drug nears approval decision

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

I can’t stop saying “loraz-a-payum” thanks to Parker Posey in “The White Lotus.”

Housekeeping note: I’ll be in New York City next week for STAT’s Breakthrough Summit East event on March 20. Therefore, this newsletter will take a one-week break. See ‘ya back on March 27.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

UnitedHealth’s next physician acquisition & the January health insurance churn

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday.

January 8, 2024

BD names ex-3M exec Ronald Silverman as chief medical officer

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Ronald Silverman, BD chief medical officer Courtesy

November 22, 2023

Bacterial communication system aids survival against antibiotics

When confronted with an antibiotic, toxic substance, or other source of considerable stress, bacteria are able to activate a defense mechanism using cell-to-cell communication to

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.